Developing an effective HIV vaccine remains one of the major challenges in global health. One promising approach focuses on so-called broadly neutralizing antibodies, antibodies that can block many different variants of HIV. However, only a small fraction of people living with the virus develop these antibodies naturally.

In a regulatory update aimed at streamlining drug export processes, the Central Drugs Standard Control Organization (CDSCO) has announced the implementation of a Prior Intimation System for Form CT-05 applications. The new system will come into force from April 21, 2026, following amendments introduced under Gazette Notification G.S.R. 50(E).

In a significant move to strengthen India’s pharmaceutical research ecosystem, the National Institute of Pharmaceutical Education and Research (NIPER), Mohali has signed an agreement with Novartis Healthcare Private Limited. The collaboration aims to promote innovation and deepen industry-academia partnerships in the country.

A new experimental drug from AstraZeneca is giving fresh hope to millions of people living with Chronic Obstructive Pulmonary Disease after showing positive results in a large late-stage study.

The drug, Tozorakimab, met its main goal in the Phase III MIRANDA trial. It helped reduce the number of serious flare-ups, also called exacerbations, in patients who were already taking standard inhaled treatments but still had symptoms.